Showing results (91-100 of 127) with videos related to
Sort By:
Pageof 13
Anti-Cancer Drug Design|March 1, 1995
Influence of the methyl substituents of a thiazole-containing lexitropsin on the mode of binding to DNAB Plouvier, R Houssin, N Helbecque, et al.Anti-Cancer Drug Design|February 1, 1992
Relationship between DNA-binding and biological activity of anilinoacridine derivatives containing the nucleic acid-binding unit SPKKF Bailly, C Bailly, N Helbecque, et al.European Journal of Biochemistry|December 18, 1991
Effect of the amine non-leaving group on the structure and stability of DNA complexes with cis-[Pt(R-NH2)2(NO3)2]J L Butour, P Alvinerie, J P Souchard, et al.Archives of Otolaryngology--Head & Neck Surgery|November 1, 1996
Port-wine stains. An assessment of 5 years of treatmentS S Orten, M Waner, S Flock, et al.Bioorganic & Medicinal Chemistry|March 16, 2001
Rebeccamycin analogues from indolo[2,3-c]carbazoleA Voldoire, M Sancelme, M Prudhomme, et al.Science (New York, N.Y.)|April 8, 1988
Electric field x-ray scattering measurements on tobacco mosaic virusM H Koch, E Dorrington, R Kläring, et al.Anti-Cancer Drug Design|October 6, 1997
Synthesis, DNA-binding and cytotoxic properties of a bis(netropsin)-anthracenedione conjugateN Boitte, N Pommery, P Colson, et al.Lasers in Surgery and Medicine|January 1, 1993
Tumor specific response to photodynamic therapyS J Stern, J Craig, S Flock, et al.Molekuliarnaia Biologiia|June 19, 2002
[HMG1 domains: the victims of circumstance]E V Chikhirzhina, A M Polianichko, A N Skvortsov, et al.Journal of Medicinal Chemistry|July 30, 1999
Substitution at the F-ring N-imide of the indolocarbazole antitumor drug NB-506 increases the cytotoxicity, DNA binding, and topoisomerase I inhibition activitiesC Bailly, X Qu, J B Chaires, et al.Pageof 13